In conclusion, due to the existence of hypoxic microenvironment in BLCA, cisplatin chemotherapy exacerbates the hypoxic state, resulting in co‐activation of STAT5A and HIF‐1α on PGK1. Here, STAT5A is linked to bladder transitional cell carcinoma.